Fresenius Kabi and Formycon Receive European Approval for Ustekinumab Biosimilar FYB202
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f6ace5614541e5be9a802456097b0e&url=https%3A%2F%2Fnews.europawire.eu%2Ffresenius-kabi-and-formycon-receive-european-approval-for-ustekinumab-biosimilar-fyb202%2Feu-press-release%2F2024%2F09%2F27%2F15%2F00%2F31%2F141241%2F&c=7921845693099084546&mkt=de-de Author : Publish date : 2024-09-27 06:00:00 Copyright for syndicated content belongs to the linked Source.